Page 3 - Pfizer

After Pfizer, Moderna starts trial of Omicron-specific Covid vaccine

US drug maker Moderna has started trial of a Covid booster vaccine that specifically targets the Omicron variant, the company has announced.

Moderna starts trial for Omicron-specific booster shot, follows Pfizer

The coronavirus variant has quickly become dominant in many parts of the world, driving up infections and straining healthcare systems.

Pfizer begins testing omicron-matched Covid-19 shots in adults

Pfizer and its partner BioNTech announced the study on Tuesday

Pfizer and BioNTech launch trial of Omicron-targeted Covid vaccine

The companies plan to test the immune response generated by the Omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot

Pfizer, CornoaVac vaccine may cause heart inflammation in adolescents

Despite low risk, there is an increased relative risk of carditis - a type of heart inflammation - associated with Covid vaccine developed by Pfizer and China's CoronaVac, researchers have found.

Annual Covid-19 vax preferred to frequent boosters, says Pfizer CEO

Albert Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March

Moderna vax may lead to fewer breakthrough Covid infections than Pfizer

Those who have received the Moderna Covid-19 mRNA vaccine are less likely to experience "breakthrough" Covid-19 cases, compared to recipients of the Pfizer-BioNTech mRNA vaccine

Two Sputnik doses provide two times higher antibodies than Pfizer: Study

A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the Omicron variant of COVID-19 than two doses of the Pfizer vaccine

FDA may authorise Pfizer's Covid vax for kids under 5 in Feb: Fauci

The US Food and Drug Administration (FDA) is likely to approve Pfizer's Covid vaccine for children under 5 years of age in February, White House chief medical advisor Anthony Fauci has said.

Hyderabad's Biophore to manufacture ingredients of Pfizer's Covid drug

Biophore India Pharmaceutical announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy

Pfizer chief Albert Bourla wins $1 mn Genesis Prize for vaccine development

Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded the prestigious Genesis Prize for his efforts in leading the development of a Covid-19 vaccine

South Korea gets first supply of Pfizer's antiviral Covid-19 pills

Health officials have described the Paxlovid pills as a potentially important tool to suppress hospitalisations and deaths

What are the new Covid-19 vaccine platforms?

Rising cases of Covid-19 have unsettled the government. It recently approved two new vaccines. But, what is the difference between these vaccines? What platforms are used to develop them? Find out

South Korea authorises Novavax Covid-19 vaccine, imports Pfizer pills

At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said

Pfizer's Omicron specific vaccine to be ready by March, says CEO

Pfizer's vaccine that specifically targets the Omicron variant of Covid-19 will be ready in March, the pharmaceutical giant's CEO Albert Bourla has said

Omicron spread: Pfizer seeks conditional EU authorisation for Covid-19 pill

The announcement comes as countries in much of the 27-nation bloc are reporting soaring numbers of infections

US CDC recommends Pfizer's Covid vaccine booster dose for ages 12 to 15

The US's CDC said it expanded the eligibility of Pfizer Inc and BioNTech SE's booster doses to those 12 to 15 years old

BioNTech, Pfizer plan shingles shot in third joint mRNA project

The partners expect to start human trials of the new vaccine in the second half of this year, they said in a statement

Covid-19: US to double order of Pfizer treatment courses, says Biden

To decrease hospitalisations and deaths from Covid, the US administration is going to double its order of Pfizer treatment courses, President Joe Biden said

US FDA authorises Pfizer-BioNTech booster shots for kids aged 12-15

The US FDA has expanded the emergency use authorisation for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.